Leading scientists Jeremy Farrar, Marion Koopmans, and Ron Fouchier will take you into the world of new infectious diseases outbreaks and show you how we can prepare for these outbreaks.
The outbreaks of the past decade have taught us that new infectious diseases continue to emerge and spread as a result of global changes. These changes include population growth, an increase in livestock and agriculture to feed the population, exponential growth of travel (tourism and trade), and climate change. Infectious diseases do not confine themselves to national borders and can spread globally, as has been shown by Zika, Ebola, MERS, and bird flu viruses. What these outbreaks have in common is that they arise unexpectedly and put our healthcare systems to the test. When an outbreak occurs, it is often difficult to intervene because there is a lack of reliable diagnostics, treatment, and vaccines at short notice.
Masterclass with Jeremy Farrar, Marion Koopmans, Ron Fouchier
Date: Thursday 4 October
Time: 15.00 – 17.00
Location: Erasmus MC, Rotterdam
Registration via: [email protected]
Rory de Vries (born 1982) is receiving the premium for his research on the human body’s defences against respiratory viral infections, and for his ability to communicate his knowledge of virology and infectious diseases to a wide audience. Rory de Vries is a post-doctoral researcher at Erasmus MC in Rotterdam.
On Thursday, 28 February 2019, the ‘One Health’ debate will take place in The Hague. This debate is the conclusion of the Castellum research programme: a public-private partnership aimed at developing vaccines against zoonoses.
Contamination with resistant bacteria in patients admitted to Dutch hospitals does not result in higher mortality than contamination by non-resistant bacteria. Although the problem of antibiotic resistance in the Netherlands currently seems manageable, it is important to remain vigilant in view of the ever-changing epidemiology of resistant bacteria, according to Wouter Rottier, who was awarded...
Radboudumc has combined its research into controlled human infection models to create a new program: the Radboudumc Controlled Human Infection Models (RCHIM). By studying the interaction between pathogens and humans under controlled conditions, researchers can improve their understanding of the underlying disease mechanisms. This understanding contributes to a more targeted development of medicines and vaccines...